🔴 Park Ha Biological Technology is trading 5% down with no clear company-specific catalyst identified

Park Ha Biological Technology is trading 5.23% lower at $2.62, with no clear company-specific catalyst identified for the intraday decline.

• A securities class-action lead-plaintiff deadline falls on September 28, but available reporting does not link it to the move.
• After President Trump rejected Iran’s proposal, oil rose and inflation concerns revived. Reuters reported higher crude prices and Treasury yields alongside falling U.S. stock futures, a risk-off backdrop not established as the cause of this decline.